Nvidia’s Blackwell, Vera Rubin Platforms Fuel 72% Growth Forecast; JPMorgan Targets $265
Nvidia’s Blackwell and Vera Rubin architectures reposition the company as a full AI factory systems provider, supporting forecasts of about 72% revenue growth in fiscal 2027. JPMorgan’s $265 price target implies 32% upside as Nvidia GPUs win adoption in drug discovery partnerships.
1. Launch of Blackwell and Vera Rubin
Nvidia introduced its Blackwell GPU architecture alongside the Vera Rubin AI platform to integrate hardware, software and services into an end-to-end AI factory solution for data centers. The company aims to leverage these platforms to extract greater monetization per AI deployment beyond traditional GPU sales.
2. Revenue growth forecast and valuation
Analyst models project fiscal 2027 revenue growth of approximately 72%, supporting current valuation multiples near 24x forward P/E and 13x forward P/S. These growth assumptions reflect broad adoption of AI workloads across cloud providers and enterprise customers.
3. Analyst price target
JPMorgan assigned a $265 price target to Nvidia shares, implying roughly 32% upside from current levels. The firm cites Nvidia’s leadership in GPU technology and expansion into AI software and systems as key upside drivers.
4. GPU applications in drug discovery
Nvidia GPUs are increasingly used in AI-driven drug discovery partnerships, enabling accelerated molecule screening and reducing R&D timelines. Meanwhile, Nvidia’s market capitalization has narrowed the gap with Alphabet to under $200 billion, reflecting investor confidence in its AI roadmap.